Pfizer seeks FDA approval for covid vaccine for children under five

The American multinational pharmaceutical company Pzifer on Wednesday finalized its emergency use request with the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccine to children under the age of 5.

Pfizer said its vaccine called “Pfizer-BioNTech COVID-19 vaccine” is 80% effective against symptomatic COVID-19 for young children.

 

“Pfizer and BioNTech have completed an ongoing application to the United States Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 vaccine for children 6 months to 4 years old (also referred to as 6 months to under 5 years old) on June 1, 2022,” the company said in a statement.

Children under 5 are the last to get vaccinated, but this also requires safety measures to be in place as this is a very sensitive target age group.

“We recognize that parents are eager to get their young children vaccinated against COVID-19 and while the FDA cannot predict how long its evaluation of the data and information will take, we will review any EUA requests we receive. as quickly as possible using a science-based approach,” the FDA said.

According to a Kaiser Family Foundation poll, many parents are hesitant to vaccinate their children as young as 5, with 27% saying they “definitely won’t” vaccinate their children in this age group. age. Only 18% plan to have their children vaccinated right away, while 38% say they would like to wait and see before deciding.

[ With inputs from agencies]

sion

You can now write for sion5ews.com and be part of the community. Share your stories and opinions with us here.